Skip to main navigation
Skip to search
Skip to main content
Augusta University Research Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Grants
Scholarly Output
Datasets
Activities
Prizes
Search by expertise, name or affiliation
The current status of oncolytic viral therapy for head and neck cancer
Matthew O. Old
, Trisha Wise-Draper
, Chadwick L. Wright
,
Balveen Kaur
, Theodoros Teknos
Research output
:
Contribution to journal
›
Review article
›
peer-review
10
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The current status of oncolytic viral therapy for head and neck cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Head-and-neck Cancer
100%
Oncolytic Virus
100%
Oncolytic Viral Therapy
100%
Head-and-neck
40%
Head-and-neck Region
40%
In Cancer
20%
Cancer Treatment
20%
Clinical Database
20%
Translational Research
20%
Moving Forward
20%
Talimogene Laherparepvec (T-VEC)
20%
Melanoma Treatment
20%
Amgen
20%
Medicine and Dentistry
Head and Neck Cancer
100%
Oncolytic Virus
100%
Oncolytic Virotherapy
100%
Neck
80%
Malignant Neoplasm
60%
Clinical Trial
20%
Nodular Melanoma
20%
Cancer Treatment
20%
Translational Research
20%
Talimogene Laherparepvec
20%
Pharmacology, Toxicology and Pharmaceutical Science
Head and Neck Cancer
100%
Oncolytic Virus
100%
Virotherapy
100%
Malignant Neoplasm
80%
Clinical Trial
20%
Melanoma
20%
Talimogene Laherparepvec
20%